{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T04:41:35Z","timestamp":1765082495913,"version":"3.46.0"},"reference-count":28,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2016,2,15]]},"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:p>Clear cell papillary renal cell carcinoma (CCPRCC) cases were evaluated for mutations on the following genes: KRAS, NRAS, BRAF, PIK3CA, ALK, ERBB2, DDR2, MAP2K1, RET and EGFR. Four male and three female patients of age 42\u201374\u2005years were evaluated. All cases were incidentally detected by ultrasound and ranged 1.8\u20133.5\u2005cm. Microscopic examination showed variably tubulopapillary, tubular acinar, cystic architecture and the characteristic linear arrangement of nuclei. The cells were reactive with CK7 (strong), CA IX (cup-shape) and 34 \u03b2 E12. CD10, AMACR\/RACEMASE and GATA3 were negative. There were no mutations on any of the investigated genes. This preliminary observation supports the concept that CCPRCC might be indeed an indolent tumour worth it to be named as clear cell papillary neoplasm of low potential.<\/jats:p>","DOI":"10.1136\/jclinpath-2015-203565","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T23:14:55Z","timestamp":1457046895000},"page":"547-550","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Genetic mutations in accordance with a low malignant potential tumour are not demonstrated in clear cell papillary renal cell carcinoma"],"prefix":"10.1136","volume":"69","author":[{"given":"Maria Rosaria","family":"Raspollini","sequence":"first","affiliation":[{"name":"Department of Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence, Italy"}]},{"given":"Francesca","family":"Castiglione","sequence":"additional","affiliation":[{"name":"Department of Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence, Italy"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[{"name":"Section of Pathological Anatomy, Department of Biomedical Sciences and Public Health Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy"}]},{"given":"Antonio","family":"Lopez-Beltran","sequence":"additional","affiliation":[{"name":"Unit of Anatomic Pathology, Department of Surgery, Cordoba University Medical School, Cordoba, Spain"},{"name":"Champalimaud Clinical Center, Lisbon, Portugal"}]}],"member":"239","published-online":{"date-parts":[[2016,3,3]]},"reference":[{"key":"2025120619112888000_69.6.547.1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000185382.80844.b1"},{"key":"2025120619112888000_69.6.547.2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318164bcbb"},{"key":"2025120619112888000_69.6.547.3","doi-asserted-by":"publisher","DOI":"10.1177\/1066896911414273"},{"key":"2025120619112888000_69.6.547.4","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318299f2d1"},{"key":"2025120619112888000_69.6.547.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.03857.x"},{"key":"2025120619112888000_69.6.547.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-011-1137-3"},{"key":"2025120619112888000_69.6.547.7","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000513"},{"key":"2025120619112888000_69.6.547.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2014.10.001"},{"key":"2025120619112888000_69.6.547.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.09.041"},{"key":"2025120619112888000_69.6.547.10","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.215"},{"key":"2025120619112888000_69.6.547.11","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000478"},{"key":"2025120619112888000_69.6.547.12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139438"},{"key":"2025120619112888000_69.6.547.13","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.91"},{"key":"2025120619112888000_69.6.547.14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1490"},{"key":"2025120619112888000_69.6.547.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-015-1859-8"},{"key":"2025120619112888000_69.6.547.16","doi-asserted-by":"publisher","DOI":"10.1309\/AH6FC77PYR2V6YAY"},{"key":"2025120619112888000_69.6.547.17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1076-5"},{"key":"2025120619112888000_69.6.547.18","doi-asserted-by":"crossref","unstructured":"Johnson WT , Patel P , Hernandez A , et al . Langerhans Cell Histiocytosis and Erdheim-Chester Disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAFV600E mutation. J Cutan Pathol 2015. doi:10.1111\/cup.12636. [Epub ahead of print] doi:10.1111\/cup.12636","DOI":"10.1111\/cup.12636"},{"key":"2025120619112888000_69.6.547.19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.2497"},{"key":"2025120619112888000_69.6.547.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2015.09.012"},{"key":"2025120619112888000_69.6.547.21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PAS.0000000000000527","article-title":"Metastatic Malignant Melanoma with Complete Loss of Differentiation Markers (Undifferentiated\/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2025120619112888000_69.6.547.22","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000377"},{"key":"2025120619112888000_69.6.547.23","doi-asserted-by":"crossref","unstructured":"Byeon HK , Na HJ , Yang YJ , et al . c-Met-mediated reactivation of PI3K\/AKT signaling contributes to insensitivity of BRAF(V600E) mutant thyroid cancer to BRAF inhibition. Mol Carcinog 2015. doi: 10.1002\/mc.22418. [Epub ahead of print] PMID: 26456083 doi:10.1002\/mc.22418","DOI":"10.1002\/mc.22418"},{"key":"2025120619112888000_69.6.547.24","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000456"},{"key":"2025120619112888000_69.6.547.25","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000446"},{"key":"2025120619112888000_69.6.547.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.08.004"},{"key":"2025120619112888000_69.6.547.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.06.032"},{"key":"2025120619112888000_69.6.547.28","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000514"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2015-203565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:11:41Z","timestamp":1765077101000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2015-203565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,3]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,5,19]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1136\/jclinpath-2015-203565"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2015-203565","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[2016,3,3]]}}}